in spanish

ReliOn Insulin Syringes Recall

On November 5, 2008, the FDA released a report on the recall of mislabeled ReliOn Insulin Syringes for diabetes. ReliOn syringes are manufactured by Tyco Healthcare Group, LP (Covidein). One lot of the syringes with permanently affixed hypodermic needles is being recalled due to potential mislabeling. According to the FDA, use of these syringes could result in an overdose of as much as 2.5 times the intended dose, and lead to hypoglycemia, other health complications and even death.

This recall applies to the following:
• Lot Number 813900
• ReliOn 1cc, 31-gauge, 100 units for use with U-100 insulin

These syringes are available only at Wal-Mart and Sam's Clubs under the ReliOn name. The FDA says that Wal-Mart is requesting customers return these syringes to their local Wal-Mart store or Sam's Club pharmacy to be issued a replacement product.

At Heygood, Orr, Reyes, Pearson & Bartolomei, we handle all manner of defective product cases. If you or a family member has been injured or has died as a result of using a ReliOn syringe, please fill out our Case Review Form to the right of this page for a free consultation.

<< BACK TO RECALLS AND WARNINGS ARCHIVE

Our Law Firm
5950 Berkshire Lane • Suite 410 • Dallas, TX 75225
214.526.7900 • Fax: 214.526.7910 • Toll Free: 877.308.7900
©2009 Reyes Bartolomei Browne. All Rights Reserved. Design, Programming and Optimization by Ad Cetera, Inc.